glp 1 mash approval Novo's Wegovy becomes first GLP-1 drug approved for glp-1 liver toxicity Fatty MASH

Some clients may experience some swelling at the injection site and nausea although, these symptoms are not as common.

doi: 10.1111/jdi.12466

Recognizing this mechanism makes it easier to select dietary and behavioral changeslike smaller, lower-fat meals and adjusted meal timingthat can blunt the nausea while preserving clinical benefit

Nothing makes us happier than keeping you happy

But behind the hype, researchers in the burgeoning field of geroscience which seeks to understand the biology of aging have been investigating whether GLP-1 drugs like Ozempic and Zepbound do more than treat obesity and diabetes

In the longer term, however, reduced obesity rates among Medicaid enrollees could also result in reduced Medicaid spending on chronic diseases associated with obesity, such as heart disease, type 2 diabetes and types of cancer, the researchers noted in a KFF news release